Patents by Inventor Ashutosh JAMLOKI

Ashutosh JAMLOKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UPADACITINIB FORMULATION
    Publication number: 20260083732
    Abstract: The present invention is related to pharmaceutical composition of upadacitinib comprising upadacitinib or its pharmaceutically acceptable salt thereof, release controlling polymer, pH modifier and one or more pharmaceutical acceptable excipient; wherein the release controlling polymer is hydrophobic polymer.
    Type: Application
    Filed: September 6, 2023
    Publication date: March 26, 2026
    Inventors: Rahul Sudhakar PATIL, Sandip Kumar Manubhai PATEL, Ashutosh JAMLOKI, Ashish SEHGAL
  • Stable oral composition of cyclophosphamide
    Patent number: 12433905
    Abstract: A stable oral composition for cyclophosphamide or its pharmaceutically acceptable salt. The composition for cyclophosphamide can be in the form of powder for oral solution, which can provide an improved stability, ease for reconstitution, and better palatability suitable for pediatric patients. Also disclosed is a process for preparation of the powder for oral solution of cyclophosphamide.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: October 7, 2025
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Venkataramana Naidu, Jwalant Vijaybhai Desai, Mayank Saxena, Ashutosh Jamloki
  • ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE
    Publication number: 20240139108
    Abstract: The present invention provides oral pharmaceutical composition comprising Arsenic trioxide and one or more pharmaceutically acceptable excipients for use in the treatment of acute promyelocytic leukemia and other cancers like acute myeloid leukemia. Further, the present invention provides a process for the preparation of the said composition.
    Type: Application
    Filed: February 25, 2022
    Publication date: May 2, 2024
    Inventors: Nirav Nitinkumar BHAVSAR, Sudhir Santosh IGHE, Ashutosh JAMLOKI, Ajeet SINGH, Ashish SEHGAL
  • PHARMACEUTICAL COMPOSITION OF TEMOZOLOMIDE
    Publication number: 20220273646
    Abstract: A stable pharmaceutical composition of temozolomide for oral administration. The pharmaceutical composition is in the form of powder for oral suspension, wherein the said powder is reconstituted with a liquid vehicle just before administration. Further the invention relates to process for the preparation of said pharmaceutical composition and its packaging in individual doses.
    Type: Application
    Filed: July 16, 2020
    Publication date: September 1, 2022
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Jwalant Vijaybhai DESAI, Mayank SAXENA, Ashutosh JAMLOKI, Venkataramana NAIDU
  • STABLE ORAL COMPOSITION OF CYCLOPHOSPHAMIDE
    Publication number: 20220265688
    Abstract: A stable oral composition for cyclophosphamide or its pharmaceutically acceptable salt. The composition for cyclophosphamide can be in the form of powder for oral solution, which can provide an improved stability, ease for reconstitution, and better palatability suitable for pediatric patients. Also disclosed is a process for preparation of the powder for oral solution of cyclophosphamide.
    Type: Application
    Filed: July 9, 2020
    Publication date: August 25, 2022
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Venkataramana NAIDU, Jwalant Vijaybhai DESAI, Mayank SAXENA, Ashutosh JAMLOKI
  • PHARMACEUTICAL COMPOSITION OF IMATINIB
    Publication number: 20220265653
    Abstract: A pharmaceutical composition having imatinib or its pharmaceutically acceptable salt thereof and one or more pharmaceutical acceptable excipients in powder form, which can be reconstituted with a diluent just before administration. Also disclosed is a process for the preparation of the composition and its use in a method for the treatment of cancer in pediatric patients.
    Type: Application
    Filed: July 15, 2020
    Publication date: August 25, 2022
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Jwalant Vijaybhai DESAI, Mayank SAXENA, Ashutosh JAMLOKI, Venkataramana NAIDU
  • PHARMACEUTICAL COMPOSITION OF EVEROLIMUS
    Publication number: 20200093804
    Abstract: The present invention relates to pharmaceutical composition comprising Everolimus and hot melt extrusion (HME) grade hydroxypropyl methylcellulose, and process for the preparation of the said composition.
    Type: Application
    Filed: February 5, 2018
    Publication date: March 26, 2020
    Inventors: Ravikumar Mahendrabhai ARDESHANA, Sandip Kumar Manubhai PATEL, Ashutosh JAMLOKI, Ashish SEHGAL